A phase 2 study of PN-235 in inflammatory bowel diseases
Latest Information Update: 09 Dec 2021
At a glance
- Drugs PN-235 (Primary)
- Indications Inflammatory bowel diseases
- Focus Therapeutic Use
- 09 Dec 2021 New trial record
- 02 Dec 2021 According to Protagonist Therapeutics media release, the company is expected to commence this trial in late 2022.